AAAAAA

   
Results: 1-25 | 26-29
Results: 1-25/29
RISK-FACTORS IN 2 POPULATIONS AT CONTRASTING RISK FOR CORONARY-ARTERYDISEASE
Authors: FERRIERES J EVANS A AMOUYEL P ARVEILER D YARNELL J RUIDAVETS JB VAGUE IJ FRUCHART JC LUC G SCARABIN PY CAMBIEN F DUCIMETIERE P
Citation: J. Ferrieres et al., RISK-FACTORS IN 2 POPULATIONS AT CONTRASTING RISK FOR CORONARY-ARTERYDISEASE, Journal of the American College of Cardiology, 31(2), 1998, pp. 147-147
ASSOCIATIONS OF FIBRINOGEN, FACTOR-VII AND PAI-1 WITH BASE-LINE FINDINGS AMONG 10,500 MALE PARTICIPANTS IN A PROSPECTIVE-STUDY OF MYOCARDIAL-INFARCTION - THE PRIME STUDY
Authors: SCARABIN PY AILLAUD MF AMOUYEL P EVANS A LUC G FERRIERES J ARVEILER D JUHANVAGUE I
Citation: Py. Scarabin et al., ASSOCIATIONS OF FIBRINOGEN, FACTOR-VII AND PAI-1 WITH BASE-LINE FINDINGS AMONG 10,500 MALE PARTICIPANTS IN A PROSPECTIVE-STUDY OF MYOCARDIAL-INFARCTION - THE PRIME STUDY, Thrombosis and haemostasis, 80(5), 1998, pp. 749-756
5 FREQUENT POLYMORPHISMS OF THE PAI-1 GENE - LACK OF ASSOCIATION BETWEEN GENOTYPES, PAI ACTIVITY, AND TRIGLYCERIDE LEVELS IN A HEALTHY POPULATION
Authors: HENRY M CHOMIKI N SCARABIN PY ALESSI MC PEIRETTI F ARVEILER D FERRIERES J EVANS A AMOUYEL P POIRIER O CAMBIEN F JUHANVAGUE I
Citation: M. Henry et al., 5 FREQUENT POLYMORPHISMS OF THE PAI-1 GENE - LACK OF ASSOCIATION BETWEEN GENOTYPES, PAI ACTIVITY, AND TRIGLYCERIDE LEVELS IN A HEALTHY POPULATION, Arteriosclerosis, thrombosis, and vascular biology, 17(5), 1997, pp. 851-858
EFFECTS OF ORAL AND TRANSDERMAL ESTROGEN PROGESTERONE REGIMENS ON BLOOD-COAGULATION AND FIBRINOLYSIS IN POSTMENOPAUSAL WOMEN - A RANDOMIZEDCONTROLLED TRIAL/
Authors: SCARABIN PY ALHENCGELAS M PLUBUREAU G TAISNE P AGHER R AIACH M
Citation: Py. Scarabin et al., EFFECTS OF ORAL AND TRANSDERMAL ESTROGEN PROGESTERONE REGIMENS ON BLOOD-COAGULATION AND FIBRINOLYSIS IN POSTMENOPAUSAL WOMEN - A RANDOMIZEDCONTROLLED TRIAL/, Arteriosclerosis, thrombosis, and vascular biology, 17(11), 1997, pp. 3071-3078
MENOPAUSAL HORMONE REPLACEMENT THERAPY AN D MORTALITY
Authors: SCARABIN PY
Citation: Py. Scarabin, MENOPAUSAL HORMONE REPLACEMENT THERAPY AN D MORTALITY, Revue d'epidemiologie et de sante publique, 45(5), 1997, pp. 440-441
EFFECTS OF ORAL AND TRANSDERMAL ESTROGEN PROGESTERONE REPLACEMENT THERAPY ON BLOOD-COAGULATION AND FIBRINOLYSIS IN POSTMENOPAUSAL WOMEN/
Authors: SCARABIN PY ALHENCGELAS M PLUBUREAU G TAISNE P AGHER R AIACH M
Citation: Py. Scarabin et al., EFFECTS OF ORAL AND TRANSDERMAL ESTROGEN PROGESTERONE REPLACEMENT THERAPY ON BLOOD-COAGULATION AND FIBRINOLYSIS IN POSTMENOPAUSAL WOMEN/, Thrombosis and haemostasis, 1997, pp. 788-788
HORMONE REPLACEMENT THERAPY, THROMBOSIS, AND HEMOSTASIS
Authors: SCARABIN PY
Citation: Py. Scarabin, HORMONE REPLACEMENT THERAPY, THROMBOSIS, AND HEMOSTASIS, Atherosclerosis, 134(1-2), 1997, pp. 113-113
POPULATION CORRELATES OF COAGULATION-FACTOR-VII - IMPORTANCE OF AGE, SEX, AND MENOPAUSAL STATUS AS DETERMINANTS OF ACTIVATED FACTOR-VII
Authors: SCARABIN PY VISSAC AM KIRZIN JM BOURGEAT P AMIRAL J AGHER R GUIZE L
Citation: Py. Scarabin et al., POPULATION CORRELATES OF COAGULATION-FACTOR-VII - IMPORTANCE OF AGE, SEX, AND MENOPAUSAL STATUS AS DETERMINANTS OF ACTIVATED FACTOR-VII, Arteriosclerosis, thrombosis, and vascular biology, 16(9), 1996, pp. 1170-1176
NEW ORAL-CONTRACEPTIVES AND VENOUS THROMBOEMBOLIC DISEASES - UNEXPECTED RESULTS
Authors: SCARABIN PY
Citation: Py. Scarabin, NEW ORAL-CONTRACEPTIVES AND VENOUS THROMBOEMBOLIC DISEASES - UNEXPECTED RESULTS, Revue d'epidemiologie et de sante publique, 44(2), 1996, pp. 188-189
RISK OF VENOUS THROMBOSIS WITH HORMONE REPLACEMENT THERAPY
Authors: SCARABIN PY
Citation: Py. Scarabin, RISK OF VENOUS THROMBOSIS WITH HORMONE REPLACEMENT THERAPY, Lancet, 348(9042), 1996, pp. 1668-1668
SAFETY OF COMBINED ORAL-CONTRACEPTIVE PILLS
Authors: PLUBUREAU G AMIRAL J GUIZE L SCARABIN PY
Citation: G. Plubureau et al., SAFETY OF COMBINED ORAL-CONTRACEPTIVE PILLS, Lancet, 347(9000), 1996, pp. 549-549
HRT AND ACE ACTIVITY IN POSTMENOPAUSAL WOMEN
Authors: SCARABIN PY BILLAUD E PLUBUREAU G AGHER R
Citation: Py. Scarabin et al., HRT AND ACE ACTIVITY IN POSTMENOPAUSAL WOMEN, Lancet, 347(8994), 1996, pp. 122-122
FACTOR-VII ARG GLN(353) POLYMORPHISM DETERMINES FACTOR-VII COAGULANT ACTIVITY IN PATIENTS WITH MYOCARDIAL-INFARCTION (MI) AND CONTROL SUBJECTS IN BELFAST AND IN FRANCE BUT IS NOT A STRONG INDICATOR OF MI RISK IN THE ECTIM STUDY/
Authors: LANE A GREEN F SCARABIN PY NICAUD V BARA L HUMPHRIES S EVANS A LUC G CAMBOU JP ARVEILER D CAMBIEN F
Citation: A. Lane et al., FACTOR-VII ARG GLN(353) POLYMORPHISM DETERMINES FACTOR-VII COAGULANT ACTIVITY IN PATIENTS WITH MYOCARDIAL-INFARCTION (MI) AND CONTROL SUBJECTS IN BELFAST AND IN FRANCE BUT IS NOT A STRONG INDICATOR OF MI RISK IN THE ECTIM STUDY/, Atherosclerosis, 119(1), 1996, pp. 119-127
BETA-FIBRINOGEN GENE POLYMORPHISMS ARE ASSOCIATED WITH PLASMA-FIBRINOGEN AND CORONARY-ARTERY DISEASE IN PATIENTS WITH MYOCARDIAL-INFARCTION- THE ECTIM STUDY
Authors: BEHAGUE I POIRIER O NICAUD V EVANS A ARVEILER D LUC G CAMBOU JP SCARABIN PY BARA L GREEN F CAMBIEN F
Citation: I. Behague et al., BETA-FIBRINOGEN GENE POLYMORPHISMS ARE ASSOCIATED WITH PLASMA-FIBRINOGEN AND CORONARY-ARTERY DISEASE IN PATIENTS WITH MYOCARDIAL-INFARCTION- THE ECTIM STUDY, Circulation, 93(3), 1996, pp. 440-449
THE 4G 5G GENETIC-POLYMORPHISM IN THE PROMOTER OF THE PLASMINOGEN-ACTIVATOR INHIBITOR-1 (PAI-1) GENE IS ASSOCIATED WITH DIFFERENCES IN PLASMA PAI-1 ACTIVITY BUT NOT WITH RISK OF MYOCARDIAL-INFARCTION IN THE ECTIM STUDY/
Authors: YE S GREEN FR SCARABIN PY NICAUD V BARA L DAWSON SJ HUMPHRIES SE EVANS A LUC G CAMBOU JP ARVEILER D HENNEY AM CAMBIEN F
Citation: S. Ye et al., THE 4G 5G GENETIC-POLYMORPHISM IN THE PROMOTER OF THE PLASMINOGEN-ACTIVATOR INHIBITOR-1 (PAI-1) GENE IS ASSOCIATED WITH DIFFERENCES IN PLASMA PAI-1 ACTIVITY BUT NOT WITH RISK OF MYOCARDIAL-INFARCTION IN THE ECTIM STUDY/, Thrombosis and haemostasis, 74(3), 1995, pp. 837-841
CHANGES IN HEMOSTATIC VARIABLES INDUCED BY ORAL-CONTRACEPTIVES CONTAINING 50 MU-G OR 30 MU-G ESTROGEN - ABSENCE OF DOSE-DEPENDENT EFFECT ONPAI-1 ACTIVITY
Authors: SCARABIN PY PLUBUREAU G ZITOUN D BARA L GUIZE L SAMAMA MM
Citation: Py. Scarabin et al., CHANGES IN HEMOSTATIC VARIABLES INDUCED BY ORAL-CONTRACEPTIVES CONTAINING 50 MU-G OR 30 MU-G ESTROGEN - ABSENCE OF DOSE-DEPENDENT EFFECT ONPAI-1 ACTIVITY, Thrombosis and haemostasis, 74(3), 1995, pp. 928-932
RELATIONSHIP BETWEEN FIBRINOLYSIS AND CARDIOVASCULAR RISK-FACTORS IN HEALTHY POPULATION AND A HYPERLIPEMIC GROUP
Authors: AMIRAI J VISSAC AM LAROSA E KIRZIN JM GUIZE L SCARABIN PY
Citation: J. Amirai et al., RELATIONSHIP BETWEEN FIBRINOLYSIS AND CARDIOVASCULAR RISK-FACTORS IN HEALTHY POPULATION AND A HYPERLIPEMIC GROUP, Thrombosis and haemostasis, 73(6), 1995, pp. 949-949
CARDIOVASCULAR RISK-FACTORS AND D-DIMER CONCENTRATIONS IN A HEALTHY POPULATION AND A HYPERLIPEMIC GROUP
Authors: VISSAC AM AMIRAL J SCARABIN PY LAROSA E BOURGEAT P KIRZIN JM GUIZE L
Citation: Am. Vissac et al., CARDIOVASCULAR RISK-FACTORS AND D-DIMER CONCENTRATIONS IN A HEALTHY POPULATION AND A HYPERLIPEMIC GROUP, Thrombosis and haemostasis, 73(6), 1995, pp. 949-949
DETERMINANTS OF FACTOR-VII ACTIVITY AND ACTIVATION IN A HEALTHY POPULATION
Authors: SCARABIN PY VISSAC AM LAROSA E BOURGEAT P AMIRAL J AGHER R GUIZE L
Citation: Py. Scarabin et al., DETERMINANTS OF FACTOR-VII ACTIVITY AND ACTIVATION IN A HEALTHY POPULATION, Thrombosis and haemostasis, 73(6), 1995, pp. 1380-1380
ASSOCIATION OF HORMONE REPLACEMENT THERAPY TO HEMOSTATIC VARIABLES INPOSTMENOPAUSAL WOMEN
Authors: SCARABIN PY ALHENCGELAS M PLUBUREAU G TAISNE P AGHER R GUIZE L AIACH M
Citation: Py. Scarabin et al., ASSOCIATION OF HORMONE REPLACEMENT THERAPY TO HEMOSTATIC VARIABLES INPOSTMENOPAUSAL WOMEN, Thrombosis and haemostasis, 73(6), 1995, pp. 1385-1385
ASSOCIATION BETWEEN LOW-DOSE COMBINATION ORAL-CONTRACEPTIVES AND HEMOSTATIC VARIABLES - IMPORTANCE OF PROGESTOGENS
Authors: PLUBUREAU G VISSAC AM LAROSA E BOURGEAT P AMIRAL I AGHER R GUIZE L SCARABIN PY
Citation: G. Plubureau et al., ASSOCIATION BETWEEN LOW-DOSE COMBINATION ORAL-CONTRACEPTIVES AND HEMOSTATIC VARIABLES - IMPORTANCE OF PROGESTOGENS, Thrombosis and haemostasis, 73(6), 1995, pp. 1385-1385
SEASONAL-VARIATIONS OF PLASMA-FIBRINOGEN IN ELDERLY PEOPLE
Authors: SCARABIN PY BARA L NICAUD V CAMBOU JP ARVEILER D LUC G EVANS AE CAMBIEN F
Citation: Py. Scarabin et al., SEASONAL-VARIATIONS OF PLASMA-FIBRINOGEN IN ELDERLY PEOPLE, Lancet, 343(8903), 1994, pp. 975-976
GENETIC-VARIATION AT THE BETA-FIBRINOGEN LOCUS IN RELATION TO PLASMA-FIBRINOGEN CONCENTRATIONS AND RISK OF MYOCARDIAL-INFARCTION - THE ECTIM STUDY
Authors: SCARABIN PY BARA L RICARD S POIRIER O CAMBOU JP ARVEILER D LUC G EVANS AE SAMAMA MM CAMBIEN F
Citation: Py. Scarabin et al., GENETIC-VARIATION AT THE BETA-FIBRINOGEN LOCUS IN RELATION TO PLASMA-FIBRINOGEN CONCENTRATIONS AND RISK OF MYOCARDIAL-INFARCTION - THE ECTIM STUDY, Arteriosclerosis and thrombosis, 13(6), 1993, pp. 886-891
HEMOSTATIC VARIABLES AND MENOPAUSAL STATUS - INFLUENCE OF HORMONE REPLACEMENT THERAPY
Authors: SCARABIN PY PLUBUREAU G BARA L BONITHONKOPP C GUIZE L SAMAMA MM
Citation: Py. Scarabin et al., HEMOSTATIC VARIABLES AND MENOPAUSAL STATUS - INFLUENCE OF HORMONE REPLACEMENT THERAPY, Thrombosis and haemostasis, 70(4), 1993, pp. 584-587
GENETIC AND ENVIRONMENTAL DETERMINANTS OF PLASMA-FIBRINOGEN IN RELATION WITH THE RISK OF MYOCARDIAL-INFARCTION - THE ECTIM STUDY
Authors: SCARABIN PY BARA L RICARD S POIRIER O CAMBOU JP ARVEILER D LUC G EVANS AE SAMAMA M CAMBIEN F
Citation: Py. Scarabin et al., GENETIC AND ENVIRONMENTAL DETERMINANTS OF PLASMA-FIBRINOGEN IN RELATION WITH THE RISK OF MYOCARDIAL-INFARCTION - THE ECTIM STUDY, Thrombosis and haemostasis, 69(6), 1993, pp. 1080-1080
Risultati: 1-25 | 26-29